Shumlin said he sent a letter Wednesday to Amphastar Pharmaceuticals Inc. urging Chief Executive Officer Jack Zhang to lower the price of naloxone.
“We implore your company to stop the steep increase in the price of naloxone, which is threatening our efforts to distribute rescue kits and save lives,” the letter states. “Opiate addiction is a disease, and in Vermont, we are treating it as such. We are reducing the stigma associated with addiction, expanding treatment and saving lives. The soaring cost of naloxone threatens to thwart our progress.”
Source: BurlingtonFreePress.com – April 9, 2015